PRKACA Antikörper (AA 1-351)
PRKACA
Reaktivität: Human
WB, IF/ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2800195
-
-
Target
Alle PRKACA Antikörper anzeigen
-
PRKACA
(Protein Kinase A, alpha (PRKACA))
-
Bindungsspezifität
-
AA 1-351
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser PRKACA Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunofluorescence (fixed cells) (IF/ICC)
-
Verwendungszweck
-
PKA C alpha antibody, 1 mg/ml
-
Immunogen
-
Recombinant fragment corresponding to a region within amino acids 1-351 of PKA C alpha
-
Isotyp
-
IgG
-
Top Product
-
Discover our top product PRKACA Primärantikörper
-
-
-
Applikationshinweise
-
ICC/IF,Western blot
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
1 mg/mL
-
Buffer
-
0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
-
Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
-
This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
-20°C
-
-
Target
-
PRKACA
(Protein Kinase A, alpha (PRKACA))
-
Andere Bezeichnung
-
PKA C alpha (PRKACA Produkte)
-
Synonyme
-
PKACA antikoerper, Calpha antikoerper, Cs-PKA antikoerper, PKCA1 antikoerper, PKA antikoerper, PKCD antikoerper, Pkaca antikoerper, zgc:158799 antikoerper, protein kinase cAMP-activated catalytic subunit alpha antikoerper, protein kinase, cAMP dependent, catalytic, alpha antikoerper, cAMP-dependent protein kinase catalytic subunit antikoerper, protein kinase, cAMP-dependent, catalytic, alpha, genome duplicate a antikoerper, PRKACA antikoerper, Prkaca antikoerper, kin-1 antikoerper, prkacaa antikoerper
-
Molekulargewicht
-
41 kDa
-
Gen-ID
-
5566
-
Pathways
-
NF-kappaB Signalweg, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-